Welcome to 2022!
To start off the year, I am excited to share the Society for Immunotherapy of Cancer’s (SITC) first Fireside Chat on a fascinating topic, the microbiome. I was able to bring together two of the pioneers in research on this topic in past president of SITC Thomas F. Gajewski, MD, PhD, University of Chicago and Jennifer A. Wargo, MD, MMSc, The University of Texas MD Anderson Cancer Center. We also were able to hear from a past NCI/SITC Immunotherapy Fellowship awardee, doctor and investigator, John Shin, MD, Loma Linda University Health.
Click here to view video on YouTube
During our chat, we dug into the microbiome extensively. Dr. Gajewski gave a great overview of what the gut microbiome is and how it can impact the effectiveness of immunotherapy. Dr. Wargo discussed her ground-breaking research on the make-up of the microbiome and how melanoma patients responded to treatment. Next, Dr. Shin discussed a novel decentralized clinical trial he has launched relating to diet and exercise and how it can impact the microbiome and its effect on immunotherapy. Lastly, I had the panel look into the crystal ball to predict how we might intervene in the microbiome in the future to impact the effectiveness of immunotherapy.
I invite you to join our conversation by leaving a comment or question in the video chat. Thank you to my guests Dr. Gajewski, Dr. Wargo and Dr. Shin for their interesting insights into the microbiome and how it can play a role in immunotherapy.